Prostate specific antigen patterns in US and European populations: comparison of six diverse cohorts

BJU International
Andrew J SimpkinChris Metcalfe

Abstract

To determine whether there are differences in prostate specific antigen (PSA) at diagnosis or changes in PSA between US and European populations of men with and without prostate cancer. Repeated measures of PSA from six clinically and geographically diverse patient cohorts: two cohorts of men with PSA-detected prostate cancer, two cohorts with clinically-detected prostate cancer and two cohorts of men without prostate cancer. Using multilevel models, average PSA at diagnosis and PSA change over time were compared between populations. Annual percentage PSA change of 4-5% was similar between men without cancer and men with PSA-detected cancer. PSA at diagnosis was 1.7ng/ml lower in a US cohort of PSA-detected men (95% CI 1.3-2.0ng/ml), compared to a PSA-detected UK cohort, but there was no evidence for a different rate of PSA change between these populations. PSA changes over time are similar in UK and US men diagnosed through PSA testing and even in men without prostate cancer. Further development of PSA models to monitor men on active surveillance should be undertaken in order to take advantage of these similarities. We found no evidence that guidelines for using PSA to monitor men cannot be passed between US and European studi...Continue Reading

References

Jun 23, 2004·Biostatistics·Lurdes Y T InoueDavid F Penson
Jun 29, 2004·Diabetes Care·Harmon EyreUNKNOWN American Cancer Society, the American Diabetes Association, and the American Heart Association.Collaborative Writing Committ
May 5, 2005·JAMA : the Journal of the American Medical Association·Peter C AlbertsenJudith Fine
Oct 31, 2006·The Journal of Urology·Timothy J DaskivichWilliam K Oh
Nov 7, 2006·The Journal of Urology·Xiaoying YuWilliam J Catalona
Jan 2, 2007·European Urology·David ConnollyPatrick F Keane
Mar 21, 2008·The New England Journal of Medicine·Martin G SandaJohn T Wei
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J VickersHans Lilja
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurence KlotzAndrew Loblaw
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ashley E RossPatrick C Walsh
Jul 27, 2010·International Journal of Cancer. Journal International Du Cancer·M Frank O'BrienUNKNOWN Trans-Atlantic Prostate Group
Dec 1, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R CooperbergPeter R Carroll
Apr 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey J TosoianH Ballentine Carter
Mar 16, 2012·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Jun 16, 2012·European Urology·Marc A Dall'EraMark S Soloway
Nov 20, 2012·European Urology·Meelan BulMonique J Roobol
Mar 12, 2013·European Urology·Elizabeth D SelvaduraiChris C Parker
Oct 11, 2013·Statistical Methods in Medical Research·Andrew J SimpkinKate Tilling
Mar 7, 2014·The New England Journal of Medicine·Anna Bill-AxelsonJan-Erik Johansson
Jul 8, 2015·JAMA : the Journal of the American Medical Association·Matthew R Cooperberg, Peter R Carroll

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
K Nutahara, E Higashihara
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
R Boissier
© 2022 Meta ULC. All rights reserved